Ibrutinib Exposure and B-Cell Depletion Induced By Anti-CD20 Monoclonal Antibodies Rituximab and Obinutuzumab: Is There a Rationale for Combination Studies? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Blood Année : 2014

Ibrutinib Exposure and B-Cell Depletion Induced By Anti-CD20 Monoclonal Antibodies Rituximab and Obinutuzumab: Is There a Rationale for Combination Studies?

Domaines

Cancer Immunologie
Fichier non déposé

Dates et versions

hal-02348895 , version 1 (05-11-2019)

Identifiants

Citer

Loic Ysebaert, Christian Klein, Anne Quillet-Mary. Ibrutinib Exposure and B-Cell Depletion Induced By Anti-CD20 Monoclonal Antibodies Rituximab and Obinutuzumab: Is There a Rationale for Combination Studies?. Blood, 2014, 124 (21), pp.1980-1980. ⟨10.1182/blood.V124.21.1980.1980⟩. ⟨hal-02348895⟩
23 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More